micafungin

Pharmacokinetics of Micafungin in Patients of Intensive Care Units

Fluconazole Versus Micafungin in Neonates With Candidiasis

Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis

A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects

Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Liver Transplant European Study Into the Prevention of Fungal Infection

Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis

Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology

Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study

Antimicrobial Revision in Persistent Febrile Neutropenia

Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis

Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients

Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection

Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins

Evaluate Bioequivalence of Micafungin (50mg/Vial)

Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia

Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin

Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease